Search

CarrerasLeaders call two is now open

The second CarrerasLeaders call is open: apply now to the postdoctoral program to empower future leaders in the fight against blood cancers.

Read more

EHA-SSH joint membership

Save money and time by becoming a joint member of EHA and the Swiss Society of Hematology. We've joined forces with the Swiss Society of Hematology (SSH) to offer a special joint membership deal.

Read more

Expert opinions for COVID-19 vaccination in patients with hematologic cancer

Ronja Brockhoff, Hamdi Akan, Rafael Duarte, Martin Hönigl, Nikolay Klimko, Sibylle C. Mellinghoff, Livio Pagano, Antonio Pagliuca, Paul Verweij, Oliver A.

Read more

EHA-ISHBT Hematology Tutorial on Lymphoproliferative and Plasma Cell Disorders

EHA Hematology Tutorial in collaboration with the Indian Society of Hematology & Blood Transfusion

Dates: February 16-18, 2018
Location: Lucknow, India
Chairs: AK Tripathi & G Gaidano

Goal of the meeting
This three day event aims to increase the knowledge of participants on how to provide…

Read more

EBAH CME policy

Welcome to the EBAH CME Accreditation policy for EHA2025 Congress. Below you will find an overview of the EBAH CME credits that can be collected for physical attendance as well as virtual attendance of the sessions.

Read more

Novel basis for chemoresistance in AML: DNMT3A R882 mutations promote chemoresistance and residual disease through impaired DNA damage sensing

Although most acute myeloid leukemia (AML) patients initially respond to chemotherapy, the majority subsequently relapses and succumbs to refractory disease. Residual leukemic cells that survived chemotherapy may persist over time and later cause the disease to come back.

Read more

Research Committee call for interest

The overarching aim of the Research Committee is to further strengthen EHA’s interactions with and relevance for the wider hematological research community.

Read more